First Time Prize Awarded to Organization, Rather Than to an Individual
WASHINGTON, DC/NEW YORK, SEPTEMBER 6, 2012—The Fulbright Association will present its 2012 J. William Fulbright Prize for International Understanding to the international medical humanitarian organization Médecins Sans Frontières (MSF) / Doctors Without Borders. The formal award ceremony is scheduled for September 8, 2012, at the Library of Congress in Washington, DC.
The award, a $50,000 prize, will be received with a speech by Dr. Unni Karunakara, international president of MSF. A further highlight of the ceremony will be a testimonial to the work of MSF by Francis Gatluak, one of the first people ever treated by MSF in South Sudan for the deadly neglected disease visceral leishmaniasis (VL). He subsequently joined MSF as a nurse to treat the people suffering from the disease that nearly took his own life, and has spent more than two decades working with VL and tuberculosis (TB) patients in his home country.
“This is the first time the Prize has been given to an organization rather than to individuals,” said Patricia Krebs, president of the Fulbright Association. “Doctors Without Borders was a unanimous first choice of the International Selection Committee because of the shared goals of the two organizations in promoting global understanding and humanitarian principles.”
The Prize was first awarded in 1993 to Nelson Mandela, who subsequently received the Nobel Peace Prize. Three other Prize laureates were also later named Nobel Prize recipients. MSF was the Nobel Prize recipient in 1999.
“The Fulbright Prize is recognition of the collective efforts of my 27,000 colleagues—some of whom were Fulbright scholars—working on the frontlines of wars and health catastrophes, not only to treat our patients, but to also promote understanding of the medical needs of the forgotten and often neglected,” said Dr. Karunakara. “It is fitting that this award is being given to our organization rather than to an individual—because it reflects the spirit and passion of Doctors Without Borders.”
MSF will utilize the funds from the Fulbright Prize to support its efforts in pioneering a more patient-friendly treatment regimen for people living with drug-resistant TB.
Mark Harrington, executive director of the Treatment Action Group, will provide a short tribute to MSF prior to the presentation of the award.
The Fulbright Association is the official American alumni organization of those provided with Fulbright grants to study, teach, and work abroad. Now in its sixty-sixth year, the Fulbright Program is the flagship international educational exchange program sponsored by the United States Government. The goal of the Fulbright Program is to increase mutual understanding and promote leadership development through learning and international cooperation. Since 1946, the Fulbright Program has provided over 300,000 participants with the opportunity to study, teach, and conduct research in the United States and more than 155 countries. Approximately 8,000 grants are awarded annually to students, teachers, scholars, artists, scientists, professionals, and host institutions.
Médecins Sans Frontières (MSF) / Doctors Without Borders is an independent international medical humanitarian organization that delivers emergency aid to people affected by armed conflict, epidemics, natural and man-made disasters, and exclusion from health care in more than 70 countries.